TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 172 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,858,406 | +10.3% | 120,990 | +61.6% | 0.05% | +6.5% |
| Q1 2023 | $1,684,141 | +545.3% | 74,884 | +607.9% | 0.05% | +411.1% |
| Q3 2022 | $261,000 | -41.6% | 10,579 | -42.6% | 0.01% | -55.0% |
| Q2 2022 | $447,000 | -65.5% | 18,437 | -63.3% | 0.02% | -67.2% |
| Q1 2022 | $1,296,000 | +332.0% | 50,285 | +420.0% | 0.06% | +221.1% |
| Q4 2021 | $300,000 | +2.7% | 9,671 | -51.6% | 0.02% | -24.0% |
| Q2 2021 | $292,000 | – | 19,990 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |